SASKATOON — In 1951, the University of Saskatchewan (USask) changed the face of nuclear medicine forever.

Nicknamed the “cancer bomb,” Dr. Harold Johns (PhD) and a team of then-graduate students that included the renowned Sylvia Fedoruk pioneered a cancer treatment using cobalt-60 radiation therapy.

At a time when traditional cancer treatments were just starting to enter the realm of nuclear medicine, the cobalt-60 therapy was a gamechanger. A true breakthrough in nuclear technology and innovation, the cobalt-60 treatment spread quickly and is responsible for helping thousands of cancer patients around the world. Its ingenuity and originality also put USask’s research on the map.

The bar set by the cobalt-60 research group is a level of excellence that USask scholars have continuously s

See Full Page